Aspire Biopharma Holdings Financial Overview
Aspire Biopharma Holdings's market cap is currently $13.51M. The company's EPS TTM is $-1.564; its P/E ratio is -0.06; Aspire Biopharma Holdings is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.